Apogee Therapeutics, Inc.
APGE · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $2,335,080 | $2,537,543 | $2,174,175 | $2,500,287 |
| - Cash | $107,914 | $124,192 | $106,916 | $141,789 |
| + Debt | $9,853 | $10,845 | $11,816 | $11,831 |
| Enterprise Value | $2,237,019 | $2,424,196 | $2,079,075 | $2,370,329 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$400 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$64,560 | -$72,766 | -$62,889 | -$75,805 |
| % Margin | – | – | – | – |
| Net Income | -$65,021 | -$66,096 | -$55,339 | -$67,218 |
| % Margin | – | – | – | – |
| EPS Diluted | -1.11 | -1.13 | -0.95 | -1.22 |
| % Growth | 1.8% | -18.9% | 22.1% | – |
| Operating Cash Flow | -$54,255 | -$62,029 | -$48,477 | -$67,714 |
| Capital Expenditures | $0 | -$768 | -$4,317 | $1 |
| Free Cash Flow | -$54,255 | -$62,797 | -$52,794 | -$67,713 |